65,437 trials
Influenza · Influenza Vaccines
Primary: Number of Subjects With H5N1 Haemagglutination-inhibition (HI) Antibody Concentrations Above the Cut-off Value — 0; 0; 0; 0 Participants
Glioblastoma
Primary: Overall Survival Rate at 12 Months (OS-12) as Estimated Using the Kaplan-Meier Method (Cohort A) — 60.0 percent of subjects alive
Healthy
Primary: Visual Acuity (VA) — 19.9; 19.83 score on a scale — p=0.890
Acute Kidney Injury
Primary: Proportion of Isotonic Crystalloid Which is 0.9% Saline — 91.2; 21.0 Percentage of fluid that was saline — p=0.001
Autoimmune Diseases
Primary: Standardized Uptake Value (SUV) for 18F-FDG for pSS Participants in Selected Body Areas — 2.9067; 5.0683; 4.0225; 1.4558 Grams per milliliter
Suicide
Primary: Beck Scale for Suicide Ideation (BSS) — 17.68; 11.6; 10.71 score on a scale
Nonconvulsive Status Epilepticus · Subclinical Seizure · Altered Mental Status
Primary: Time Difference Between EEG Cap and Standard EEG Results Reporting — 103.4 minutes — p=0.0005
Conjunctivitis · Conjunctivitis, Bacterial
Primary: Number of Adverse Events (EAS) — 11; 10 adverse events — p=0.749
Non-Alcoholic Fatty Liver Disease
Primary: Percentage of Liver Fat — -7.9; -4.6 percentage of liver fat — p=0.48
Vaccine Responsiveness in Allergy · Vaccine Responsiveness During Allergy De-sensitization Treatment
Primary: Humoral TBE Immunity — 317.90; 250.10; 282.20 titer
Breast Cancer
Primary: Disease Free Survival (DFS) Events — 105; 120 Participants
Respiratory Diseases
Primary: Patient Satisfaction of the Alternative Consultation — 5.85; 5.67; 5.26; 5.47 score on a scale
Moderate and Severe Active Rheumatoid Arthritis · Active Psoriatic Arthritis · Active Ankylosing Spondylitis
Primary: Percentage of Subjects Able to Self-administer Safe and Effective Injections Using the e-Device at Visit 2 — 100.00; 96.88 percentage of subjects
Behavior · Cardiovascular Risk Factor · Influenza
Primary: Average Take-up of Preventive Services (Post-consultation) — 0.52; .71 score on a scale
Migraine Headaches
Primary: Assess the Utility of Telemedicine for Follow-up Care in a Headache Medicine Practice — 87; 92.7 percentage of scheduled appointments